SOMA LABS, INC. VS. MANAVKUMAR G. SHAH (C-000114-13, MIDDLESEX COUNTY AND STATEWIDE)

CourtNew Jersey Superior Court Appellate Division
DecidedMay 13, 2019
DocketA-4685-16T1
StatusUnpublished

This text of SOMA LABS, INC. VS. MANAVKUMAR G. SHAH (C-000114-13, MIDDLESEX COUNTY AND STATEWIDE) (SOMA LABS, INC. VS. MANAVKUMAR G. SHAH (C-000114-13, MIDDLESEX COUNTY AND STATEWIDE)) is published on Counsel Stack Legal Research, covering New Jersey Superior Court Appellate Division primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
SOMA LABS, INC. VS. MANAVKUMAR G. SHAH (C-000114-13, MIDDLESEX COUNTY AND STATEWIDE), (N.J. Ct. App. 2019).

Opinion

NOT FOR PUBLICATION WITHOUT THE APPROVAL OF THE APPELLATE DIVISION This opinion shall not "constitute precedent or be binding upon any court." Although it is posted on the internet, this opinion is binding only on the parties in the case and its use in other cases is limited. R. 1:36-3.

SUPERIOR COURT OF NEW JERSEY APPELLATE DIVISION DOCKET NO. A-4685-16T1

SOMA LABS, INC.,

Plaintiff-Respondent,

v.

MANAVKUMAR G. SHAH and VITACARE PHARMA, LLC, f/k/a VITACARE LABS, LLC,

Defendants-Appellants,

and

PRIME PACK, LLC, d/b/a PRIME PHARMACEUTICALS,

Defendant. _____________________________

Argued January 31, 2019 – Decided May 13, 2019

Before Judges Simonelli, O'Connor and DeAlmeida.

On appeal from Superior Court of New Jersey, Chancery Division, Middlesex County, Docket No. C- 000114-13. Susheela V. Verma argued the cause for appellants (Law Offices of Susheela Verma, attorneys; Susheela V. Verma, of counsel and on the brief; Mildred V. Spiller, on the brief).

Larry E. Hardcastle, II, argued the cause for respondent (Lanciano & Associates, LLC, attorneys; Larry E. Hardcastle, II, on the brief).

PER CURIAM

In this matter, plaintiff Soma Labs, Inc. (Soma) alleged that its former

employee, defendant Manavkumar G. Shah, misappropriated its trade secrets

and breached a confidentiality and non-solicitation agreement by, in part,

soliciting Soma's major customer on behalf of Shah's business, defendant

VitaCare Pharma, LLC (VitaCare), a competitor of Soma.1 Defendants

prevailed at trial, but appeal from the March 13, 2015 Chancery Division order

denying their motion for leave to amend their answer to assert a counterclaim

against Soma and a third-party complaint against Soma's principal, John

Botzolakis. Defendants also appeal from two separate May 22, 2017 orders

denying their motion for frivolous litigation sanctions pursuant to N.J.S.A.

1 We shall sometimes collectively refer to Shah and VitaCare as defendants.

A-4685-16T1 2 2A:15-59.1 and Rule 1:4-8, and their motion for fee-shifting under the New

Jersey Trade Secrets Act (NJTSA), N.J.S.A. 56:15-1 to -9.2 We affirm.

I.

We first address the denial of defendants' motions for frivolous litigation

sanctions under N.J.S.A. 2A:15-59.1 and Rule 1:4-8. The following facts inform

our review.

Soma manufactures custom dietary supplements known as nutraceuticals,

which it ships to its customers who then sell them to the public under the

customers' brand names and labels. Nutraceuticals are foods or tablets

containing health-giving additives. To create a nutraceutical tablet, "[i]n

general, you take a mixed blend; you put it into the hoppers of a tablet machine;

get the weight, the hardness, the thickness. And once it's approved by the lab,

then it's run." However, in order to create the "mixed blend," the "manufacturer

must determine whether the formula is directly compressible in a tablet press or

will require granulation before it is compressible."

2 Defendants also appealed from the June 18, 2015 order denying their motion for reconsideration of the March 13, 2015 order; however, they failed to address this issue in their merits brief. The issue, therefore, is deemed waived. See Sklodowsky v. Lushis, 417 N.J. Super. 648, 657 (App. Div. 2011); Pressler & Verniero, Current N.J. Court Rules, cmt. 5 on R. 2:6-2 (2019). A-4685-16T1 3 "Directly compressible means you can take that mixture, mix it, and put it

directly onto the tablet machine; it will run it." Where granulation is required,

"[i]t means the flow may be bad, the compressibility may not be good;

everything. There’s a list of things that may not allow the material to be

compressed." Further, granulation is a lengthier process, taking "at least

[twenty], [twenty-five]" hours more than direct compression.

Soma claimed it developed two processes, alleged to be trade secrets,

which would permit direct compression of mixtures otherwise requiring

granulation. The first purported trade secret was used to introduce moisture into

the mixture through a completely dry ingredient (the 1:1 trade secret). The

second purported trade secret eliminated undesirable tablet characteristics that

would otherwise have to be eliminated through granulation (the ratio trade

secret).

Shah learned of the two processes during his employment with Soma. In

November 2008, Shah executed a confidentiality and non-solicitation agreement

(agreement), which precluded him from disclosing or using any of Soma's

confidential information and trade secrets, soliciting any of Soma's customers

for a three-year period following termination of his employment, or hiring any

of Soma's employees.

A-4685-16T1 4 Shortly after Shah's resignation in January 2011, Soma analyzed his

computer and discovered that he removed some of Soma's confidential

information while still employed, having sent it from his work email address to

his personal email address. Soma also discovered that Shah forwarded

additional Soma business information to his personal email address after his

resignation and that defendants had hired a former Soma employee.

Soma later discovered, in June 2013, that Shah had solicited a "large"

customer of Soma, discussing pricing for manufacturing nutraceuticals. As a

result, Soma filed a complaint against defendants asserting claims for breach of

the duty of loyalty, misappropriation of confidential and proprietary

information, tortious interference with contract, tortious interference with

prospective economic advantage, breach of contract, breach of the implied

covenant of good faith and fair dealing, unjust enrichment, violation of the

Computer System Act, N.J.S.A. 2A:38A-1 to -6, and misappropriation of trade

secrets. Soma later filed an amended complaint adding claims of conversion,

violation of the NJTSA, and fraudulent concealment and destruction of

evidence.

The parties engaged in extensive motion practice during this litigation.

Defendants repeatedly argued before Judge Frank M. Ciuffani that Soma's trade

A-4685-16T1 5 secrets claims were frivolous and "nothing more than a hoax" to harass

defendants and stifle competition. Notably, however, defendants consented to

the entry of temporary restraints, enjoining them, in part, from "using or

disclosing any confidential or proprietary information of [Soma,]" which

remained in effect throughout the litigation. In addition, Soma withstood

defendants' motion for partial summary judgment, attempts to bar Soma's expert,

and defendants' motion for involuntary dismissal at the close of Soma's

Soma's central claim was that defendants misappropriated Soma's trade

secrets. Defendants' expert testified at the trial that the 1:1 trade secret was

actually a process in the public domain referred to as "moisture activated dry

granulation." He also testified that the ratio trade secret was in the public

domain, pointing to a nutraceutical product line, available at Walmart, that he

believed utilized the ratio trade secret in its manufacturing process.

Judge Ciuffani ultimately held that Soma failed to prove that the 1:1 trade

secret and ratio trade secret were trade secrets or that Shah took trade secrets.

In reaching this conclusion, the judge found Soma failed to protect the

Free access — add to your briefcase to read the full text and ask questions with AI

Related

McKeown-Brand v. Trump Castle Hotel & Casino
626 A.2d 425 (Supreme Court of New Jersey, 1993)
Fagas v. Scott
597 A.2d 571 (New Jersey Superior Court App Division, 1991)
First Atlantic Federal Credit Union v. Perez
918 A.2d 666 (New Jersey Superior Court App Division, 2007)
Ferolito v. Park Hill Association
975 A.2d 473 (New Jersey Superior Court App Division, 2009)
Kernan v. One Washington Park Urban Renewal Associates
713 A.2d 411 (Supreme Court of New Jersey, 1998)
Masone v. Levine
887 A.2d 1191 (New Jersey Superior Court App Division, 2005)
FRANKLIN MED. v. Newark Public Sch.
828 A.2d 966 (New Jersey Superior Court App Division, 2003)
Seidenberg v. Summit Bank
791 A.2d 1068 (New Jersey Superior Court App Division, 2002)
Sons of Thunder, Inc. v. Borden, Inc.
690 A.2d 575 (Supreme Court of New Jersey, 1997)
Wilson v. Amerada Hess Corp.
773 A.2d 1121 (Supreme Court of New Jersey, 2001)
DeBrango v. Summit Bancorp
745 A.2d 561 (New Jersey Superior Court App Division, 2000)
LoBiondo v. Schwartz
970 A.2d 1007 (Supreme Court of New Jersey, 2009)
Notte v. Merchants Mutual Insurance
888 A.2d 464 (Supreme Court of New Jersey, 2006)
Yield Dynamics, Inc. v. TEA Systems Corp.
66 Cal. Rptr. 3d 1 (California Court of Appeal, 2007)
United Hearts, LLC v. Zahabian
971 A.2d 434 (New Jersey Superior Court App Division, 2009)
Gemini Aluminum Corp. v. California Custom Shapes, Inc.
116 Cal. Rptr. 2d 358 (California Court of Appeal, 2002)
Horowitz v. Weishoff
787 A.2d 236 (New Jersey Superior Court App Division, 2001)
Belfer v. Merling
730 A.2d 434 (New Jersey Superior Court App Division, 1999)
Trocki Plastic Surg. Ctr. v. Bartkowski
782 A.2d 447 (New Jersey Superior Court App Division, 2001)
Lipkowitz v. Hamilton Surgery Ctr.
999 A.2d 1199 (New Jersey Superior Court App Division, 2010)

Cite This Page — Counsel Stack

Bluebook (online)
SOMA LABS, INC. VS. MANAVKUMAR G. SHAH (C-000114-13, MIDDLESEX COUNTY AND STATEWIDE), Counsel Stack Legal Research, https://law.counselstack.com/opinion/soma-labs-inc-vs-manavkumar-g-shah-c-000114-13-middlesex-county-and-njsuperctappdiv-2019.